TITLE

In reply

AUTHOR(S)
Niewold, Timothy B.; Swaroop, Vege Santhi
PUB. DATE
August 2003
SOURCE
Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p1054
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Replies to issues raised by Weenig and Pittelkov concerning findings of a 'Mayo Clinic Proceedings' report on the diagnosis of cutaneous T-cell lymphoma. Cross-reactivity of some polyclonal CD3 immuno-phenotyping assays with natural killer cells; Primary cutaneous T-cell lymphoma; Appearance and histological features of the patient's lymphoma.
ACCESSION #
10914702

 

Related Articles

  • Cutaneous T-Cell Lymphoma. Weenig, Roger H.; Pittelkow, Mark R.; Niewold, Timothy B.; Swaroop, Vege Santhi // Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p1054 

    Comments on the findings of a report by Niewold and Swaroop in the 2003 issue of 'Mayo Clinic Proceedings' and the issues they raised concerning the diagnosis of cutaneously lymphomas. Immunophenotype of the lymphoma; Most indolent and most common form of primary cutaneous T-cell lymphoma;...

  • MYC Immunohistochemistry Assessment in High-Grade Lymphomas: Hit or Miss? Bigras, Gilbert // American Journal of Clinical Pathology;Feb2016, Vol. 145 Issue 2, p155 

    The author presents insights on the use of MYC immunohistochemistry assessment in diagnosing high-grade lymphomas. He states that 10 to 15% of diffuse large cell B-Cell lymphomas (DLBCL) are MYC driven. He cites a study which describes an IHC method for identifying DLBCL with increased MYC...

  • Treatment for orbital diffuse large B-cell lymphoma in an elderly patient by autologous cytokine-induced killer cells. Li, Su-Xia; Zhu, Hong-Li; Guo, Bo; Lu, Xue-Chun; Yang, Bo; Liu, Yang; Han, Wei-Dong; Wang, Yao; Yao, Shan-Qian // Annals of Hematology;Apr2012, Vol. 91 Issue 4, p639 

    A letter to the editor is presented which discusses the effectivity of autologous cytokine-induced killer (CIK) cells as treatment for patient with orbital diffuse large B-cell lymphoma.

  • Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. Ohyama, Chikara; Tsuboi, Shigeru; Fukuda, Minoru // EMBO Journal;3/15/99, Vol. 18 Issue 6, p1516 

    Aberrant expression of cell surface carbohydrates such as sialyl Lewis X is associated with tumor formation and metastasis. In order to determine the roles of sialyl Lewis X in tumor metastasis, mouse melanoma B16-F1 cells were stably transfected with α1,3-fucosyl-transferase III to express...

  • Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors. Pilones, Karsten A.; Aryankalayil, Joseph; Demaria, Sandra // Clinical & Developmental Immunology;2012, p1 

    Natural killer T (NKT) cells are a small population of lymphocytes that possess characteristics of both innate and adaptive immune cells. They are uniquely poised to respond rapidly to infection and inflammation and produce cytokines that critically shape the ensuing adaptive cellular response....

  • Blastic plasmacytoid dendritic cell neoplasm presenting with a cutaneous tumor alone as the first symptom of onset: A case report and review of literature. GUOHUA YU; WEI WANG; YEKUN HAN; JING LIU; XUBO PAN; GUIMEI QU // Oncology Letters;2015, Vol. 9 Issue 2, p819 

    Blastic plasmacytoid dendritic cell neoplasm (BPDCN), formerly named cluster of differentiation (CD)4+/CD56+ haematodermic neoplasm or blastic natural killer cell lymphoma, is a rare and highly aggressive haematopoietic malignancy. BPDCN typically occurs in the elderly, with a marked...

  • Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma. van de Donk, N W C J; Kamps, S; Mutis, T; Lokhorst, H M // Leukemia (08876924);Feb2012, Vol. 26 Issue 2, p199 

    The introduction of autologous stem cell transplantation combined with the introduction of immunomodulatory drugs (IMiDs) and proteasome inhibitors has significantly improved survival of multiple myeloma patients. However, ultimately the majority of patients will develop refractory disease,...

  • Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells. Ray, A; Das, D S; Song, Y; Richardson, P; Munshi, N C; Chauhan, D; Anderson, K C // Leukemia (08876924);Jun2015, Vol. 29 Issue 6, p1441 

    The article presents a study that determines the interaction between PD1 receptor and plasmacytoid dendritic cells (pDCs) to induce cell growth in multiple myeloma (MM). Overview of the background of the study which observes how the receptors may contribute to both T-cell and immune dysfunction...

  • Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Huang, J. J.; Jiang, W. Q.; Lin, T. Y.; Huang, Y.; Xu, R. H.; Huang, H. Q.; Li, Z. M. // Annals of Oncology;Jan2011, Vol. 22 Issue 1, p149 

    Background: Extranodal natural killer (NK)/T-cell lymphoma (ENKL) is a heterogeneous entity with poor survival, requiring risk stratification in affected patients. We proposed absolute lymphocyte count (ALC) as a new prognostic factor in ENKL.Patients and methods: We retrospectively analyzed 128...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics